QA: Mersana Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001442836_2025_Mersana_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001442836, Mersana Therapeutics Inc

  xvar xval
0 AssetsCurrent 136,904,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 7,759,000
4 LiabilitiesCurrent 62,458,000
5 LiabilitiesNoncurrent 91,714,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,614,587
9 ResearchAndDevelopmentExpense -8,168,791
10 remainder_Expenses 7,627,469
11 remainder_Revenues 39,564,905
12 remainder_NetIncome 5,303,228
13 remainder_ComprehensiveNetIncome 79,139
  yvar yval
0 Assets 144,663,000
1 Liabilities 154,172,000
2 Expenses 18,073,265
3 Revenues 39,564,905
4 StockholdersEquity -9,509,000
5 NetIncome 26,794,868
6 ComprehensiveNetIncome 26,834,438
7 BaseVar 180,927,768
8 EconomicCapitalRatiobeforeLimitedLiability 0.0409
9 EconomicCapitalRatio 1.45

Edgar->Model Mapping

Feature Distribution

Change over Time